These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1580938)
1. [Immunohistochemical detection of steroid receptors in normal and pathologic human endometrium]. Bergeron C Ann Pathol; 1992; 12(1):3-11. PubMed ID: 1580938 [No Abstract] [Full Text] [Related]
2. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma. Hamid AA; Mandai M; Fujita J; Nanbu K; Kariya M; Kusakari T; Fukuhara K; Fujii S Int J Gynecol Pathol; 2003 Jul; 22(3):240-7. PubMed ID: 12819390 [TBL] [Abstract][Full Text] [Related]
3. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue. Mylonas I; Makovitzky J; Shabani N; Richter DU; Kuhn C; Jeschke U; Briese V; Friese K Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):101-8. PubMed ID: 15596282 [TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes]. Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
6. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors. Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812 [TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148 [TBL] [Abstract][Full Text] [Related]
8. Tenascin expression in normal and abnormal human endometrium. Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462 [TBL] [Abstract][Full Text] [Related]
9. Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium. Rasty G; Murray R; Lu L; Kubilis P; Benrubi G; Masood S Ann Clin Lab Sci; 1998; 28(3):138-43. PubMed ID: 9646853 [TBL] [Abstract][Full Text] [Related]
10. Sex steroid receptors in endometrial hyperplasia and neoplasia [proceedings]. Gurpide E Acta Cytol; 1980; 24(6):483-5. PubMed ID: 6934674 [TBL] [Abstract][Full Text] [Related]
11. Steroid receptors in normal, hyperplastic and malignant human endometria. Vihko R; Jänne O; Kauppila A Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Gold LI; Saxena B; Mittal KR; Marmor M; Goswami S; Nactigal L; Korc M; Demopoulos RI Cancer Res; 1994 May; 54(9):2347-58. PubMed ID: 8162580 [TBL] [Abstract][Full Text] [Related]
13. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium. Otani T; Minami S; Yamoto M; Umesaki N Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411 [TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma protein expression in endometrial hyperplasia and carcinoma. Niemann TH; Yilmaz AG; McGaughy VR; Vaccarello L Gynecol Oncol; 1997 May; 65(2):232-6. PubMed ID: 9159330 [TBL] [Abstract][Full Text] [Related]
15. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions]. Ma XX; Zhang SL; Gao S; Lu JM; Dong F Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363 [TBL] [Abstract][Full Text] [Related]
16. [The realization of the antiestrogen effect of tamoxifen in endometrial adenomatosis in women of reproductive age]. Putyrskaia NP; Chernukha GE Akush Ginekol (Mosk); 1993; (6):43-6. PubMed ID: 8311158 [TBL] [Abstract][Full Text] [Related]
17. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1. Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066 [TBL] [Abstract][Full Text] [Related]
18. Total sialic acid content in endometrial cancer tissue in relation to normal and hyperplastic human endometrium. Paszkowska A; Cybulski M; Semczuk A; Postawski K; Berbe H Cancer Detect Prev; 2000; 24(5):459-63. PubMed ID: 11129988 [TBL] [Abstract][Full Text] [Related]
19. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091 [TBL] [Abstract][Full Text] [Related]
20. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables. Ozuysal S; Oztürk H; Bilgin T; Filiz G Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]